|
|
|
|
| LEADER |
01037nam a22002417a 4500 |
| 003 |
GR-PaULI |
| 005 |
20201228092425.0 |
| 007 |
ta |
| 008 |
201118s1992 - ||||f |||| 001 0 eng d |
| 952 |
|
|
|0 0
|1 0
|2 nlm
|4 0
|6 W_841_FIS
|7 1
|9 245248
|a MEDI
|b MEDI
|c DON
|d 2020-11-18
|i 1355
|l 0
|o W 84.1 FIS
|p 025000176371
|r 2020-11-18 00:00:00
|t 1
|v 2020.00
|w 2020-11-18
|y BK15
|z Δωρεά I. Popovitch
|
| 999 |
|
|
|c 148040
|d 148040
|
| 020 |
|
|
|a 0671738445
|
| 040 |
|
|
|a GR-PaULI
|b gre
|c GR-PaULI
|e AACR2
|
| 060 |
|
|
|a W 84.1
|
| 100 |
1 |
|
|9 184385
|a Fisher, Jeffrey A.
|e συγγραφέας
|
| 245 |
1 |
0 |
|a Rx2000 :
|b breakthroughs in health, medicine, and longevity by the year 2000 and beyond /
|c Jeffrey A. Fisher.
|
| 260 |
|
|
|a New York :
|b Simon & Schuster,
|c 1992.
|
| 300 |
|
|
|a 271 σ. ;
|c 24 εκ.
|
| 504 |
|
|
|6 Περιλαμβάνει βιβλιογραφία και ευρετήριο.
|
| 650 |
|
4 |
|9 43159
|a Κοινωνικές υπηρεσίες
|x Υγεία
|
| 650 |
|
4 |
|9 3912
|a Βιοϊατρική τεχνολογία
|
| 942 |
|
|
|2 nlm
|c BK15
|
| 998 |
|
|
|c ΜΑΝΙΑΚΗ
|d 2020
|
